A revised version of the psychoticism scale
Abstract
In view of certain psychometric deficiencies of the original Psychoticism scale, an attempt was made to improve the scale by adding new items. It was attempted to increase the internal reliability of the scale, improve the shape of the distribution and increase the mean and variance score. Two different studies are discussed. Reliabilities are now somewhat improved, distributions are closer to normal and mean scores are higher than on the old scale. Four new short 12-item scales for the measurement of P, E, N and L are also given.
References (10)
- D.V.M. Bishop
The P scale and psychosis
J. abnorm. Psychol.
(1977) - J. Block
P scale and psychosis: continued concerns
J. abnorm. Psychol.
(1977) - J. Block
The Eysencks and psychoticism
J. abnorm. Psychol.
(1977) - R.B. Cattell et al.
The importance of factor trueness and of validity versus homogeneity and orthogonality in test scales
Educ. psychol. Measur.
(1964) - G. Claridge
Psychoticism
Cited by (2328)
Life satisfaction components and all-cause and cause-specific mortality: A large prospective cohort study
2024, Journal of Affective DisordersWhich life satisfaction components could be a target of positive psychological interventions for longevity is largely unknown. We aimed to investigate association of the composite measure of life satisfaction and its individual components with mortality.
This cohort study included UK Biobank participants who responded to questions concerning five components of life satisfaction at baseline. We generated a composite score representing overall life satisfaction, ranging from 0 (lowest) to 5 (highest). The outcomes were all-cause and cause-specific mortality. We used multivariable Cox regression to estimate hazard ratios (HR) for the associations of interest.
Among 165,842 eligible participants, 12,261 all-cause deaths were observed over a median of 12.9-year follow-up. Overall life satisfaction was inversely associated with all-cause mortality (adjusted HR 0.94 [95% CI: 0.93–0.95] per 1 score increment). Health satisfaction showed the strongest association with all-cause mortality, with a fully adjusted HR of 0.52 (95% CI: 0.49–0.55) for high/extreme satisfaction and 0.63 (95% CI: 0.59–0.66) for moderate satisfaction, compared with unsatisfaction (P-trend<0.001), independent of other satisfaction components, regardless of physical health and sociodemographics. The association for family, friendship, work and financial satisfaction was attenuated when adjusted for other life satisfaction components. Similar findings were observed for cause-specific mortality.
Observational study with single baseline measurement of life satisfaction precludes the ability to establish causal relationship.
Higher overall life satisfaction was associated with lower mortality. As the major contributor to lower mortality regardless of physical health and sociodemographics, health satisfaction could be an important target of positive psychological interventions for longevity.
What is wrong with individual differences research?
2024, Personality and Individual DifferencesThere are major but largely-unrecognised problems with all individual differences research which uses questionnaires or tests. Firstly, measurement specialists are vocal in observing that rating scales and ability scales cannot, in principle, measure individual differences. This may make psychometrics “a pathology of science” (Michell, 2000). Secondly, online data collection is known to produce seriously flawed results unless great care is taken when designing studies as inattention, “clicking for cash”, and automated systems (“bots”) masquerading as people have been shown to seriously affect the quality of online data. Thirdly, some scales have been developed through repeatedly paraphrasing the same item. We discuss why such scales are problematical, and why they are often validated inappropriately. Finally, we show that scales which supposedly measure quite different traits contain items having almost identical meanings. This artificially inflates the correlation between these scales and will inevitably lead to meaningless analyses, “models” and interpretation of correlations. We discuss some possible solutions to each of these issues.
Trait irritability and temporal discounting: Exploring potential sociocultural moderators
2024, Personality and Individual DifferencesIrritability is linked with poor clinical outcomes in adults. However, few studies have examined the mechanisms linking these associations, and none examine whether sociocultural factors moderate these associations. Given evidence that both pediatric irritability and lower social class are associated with preferences for smaller immediate versus larger delayed rewards (i.e., temporal discounting [TD]), the present study examines irritability, social class, and TD rates in two independent adult samples (N = 362; N = 415). We also examine if resource predictability and uncertainty moderate irritability-TD associations. Trait irritability was unrelated to TD rates in either sample. Higher subjective and objective social class and higher rates of predictability in one's life were associated with lower TD rates, but only in Sample 2 and only for one of the TD tasks. Only beliefs about uncertainty in one's life interacted with trait irritability to predict TD rate and was limited to Sample 2 and one TD task. These results suggest that trait irritability in a non-clinical adult sample is not related to impulsive decision-making assessed via TD tasks and highlight the importance of sociocultural factors in irritability research.
Predictors of response to intranasal ketamine in patients hospitalized for treatment-resistant depression
2024, Personalized Medicine in PsychiatryKetamine is recognized as an effective treatment for major depressive disorder but there remains a need to identify predictors of response to ketamine therapy.
This naturalistic study was a retrospective analysis of data from 48 patients with treatment-resistant depression who received up to four doses of intranasal ketamine in an acute psychiatric hospital setting. Baseline demographic and clinical variables were examined as potential predictors of response along with treatment-emergent dissociation and blood pressure changes. Response was defined as a depression score decrease of 50% or more from baseline measured with the Hamilton Depression Rating Scale or the Montgomery–Åsberg Depression Rating Scale.
The response rate was significantly lower in patients diagnosed with a personality disorder, the most common of which was borderline personality disorder. In contrast, baseline scores on patient-reported questionnaires assessing maladaptive personality traits were not associated with lower response rates. Adverse childhood experiences and dissociation during treatment were associated with higher response rates.
Patients with significant childhood trauma appeared to benefit more from ketamine treatment, consistent with previous research. More research to determine if personality disorders influence ketamine response is needed and should distinguish clinical diagnoses from those derived solely from patient-reported questionnaires. Treatment-emergent dissociation could be a predictor of response to intranasal ketamine but requires further study.
Neuroticism and the Risk of Atrial Fibrillation: An Observational Epidemiologic and Mendelian Randomization Study
2024, JACC: AsiaThe association between neuroticism and atrial fibrillation (AF) remains unknown.
This study aimed to assess the epidemiological and causal relationships between neuroticism and AF.
Individuals without AF history were selected From the UK Biobank nationwide prospective cohort study. Participants were divided into 2 groups (high and low) based on the median summary score from a self-questionnaire of 12 neurotic behavior domains. The 10-year AF risk was compared between the neuroticism score groups using inverse probability of treatment weighting. The causal relationship between neuroticism and AF was evaluated using a 2-sample summary-level Mendelian randomization with the inverse variance–weighted method.
Of 394,834 participants (mean age 56.3 ± 8.1 years, 45.9% male), AF occurred in 23,509 (6.0%) during a 10-year follow-up. The risk of incident AF significantly increased in the high neuroticism score group (score ≥4) (inverse probability of treatment weighting–adjusted HR: 1.05; 95% CI: 1.02-1.09; P = 0.005) compared with the low neuroticism group. In the subgroup analysis, younger age, lower body mass index, or nonsmoker/ex-smoker participants were particularly susceptible to increased AF risk due to high neuroticism scores. A Mendelian randomization analysis showed a significant causal relationship between an increase in neuroticism score and increased risk of AF (OR by inverse variance–weighted method 1.06; 95% CI: 1.02-1.11; P = 0.007) without evidence of reverse causality.
There was a significant longitudinal and causal relationship between neuroticism and AF. An integrated care including active mental health screening and management may benefit in high-risk populations.
Polygenic Analyses Show Important Differences Between Major Depressive Disorder Symptoms Measured Using Various Instruments
2024, Biological PsychiatrySymptoms of major depressive disorder (MDD) are commonly assessed using self-rating instruments like the Patient Health Questionnaire-9 (PHQ-9) (current symptoms) and the Composite International Diagnostic Interview Short-Form (CIDI-SF) (worst-episode symptoms). We performed a systematic comparison between them for their genetic architecture and utility in investigating MDD heterogeneity.
Using data from the UK Biobank (n = 41,948–109,417), we assessed the single nucleotide polymorphism heritability and genetic correlation (rg) of both sets of MDD symptoms. We further compared their rg with non-MDD traits and used Mendelian randomization to assess whether either set of symptoms has more genetic sharing with non-MDD traits. We also assessed how specific each set of symptoms is to MDD using the metric polygenic risk score pleiotropy. Finally, we used genomic structural equation modeling to identify factors that explain the genetic covariance between each set of symptoms.
Corresponding symptoms reported through the PHQ-9 and CIDI-SF have low to moderate genetic correlations (rg = 0.43–0.87), and this cannot be fully attributed to different severity thresholds or the use of a skip structure in the CIDI-SF. Both Mendelian randomization and polygenic risk score pleiotropy analyses showed that PHQ-9 symptoms are more associated with traits that reflect general dysphoria, whereas the skip structure in the CIDI-SF allows for the identification of heterogeneity among likely MDD cases. Finally, the 2 sets of symptoms showed different factor structures in genomic structural equation modeling, reflective of their genetic differences.
MDD symptoms assessed using the PHQ-9 and CIDI-SF are not interchangeable; the former better indexes general dysphoria, while the latter is more informative about within-MDD heterogeneity.